Srinivas Mummidi Selected Research

Infections

1/2021	Association of HIV-1 Infection and Antiretroviral Therapy With Type 2 Diabetes in the Hispanic Population of the Rio Grande Valley, Texas, USA.
5/2007	Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells.
11/2005	Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells.
2/2005	Contrasting effects of natural selection on human and chimpanzee CC chemokine receptor 5.
10/2002	HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srinivas Mummidi Research Topics

Disease

8	Obesity 01/2021 - 02/2008
7	Inflammation (Inflammations) 02/2024 - 07/2003
7	Insulin Resistance 01/2021 - 02/2008
5	Infections 01/2021 - 10/2002
5	Hypertrophy 10/2015 - 02/2005
5	Acquired Immunodeficiency Syndrome (AIDS) 08/2015 - 05/2007
4	Fibrosis (Cirrhosis) 02/2024 - 10/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2007
4	Neoplasms (Cancer) 01/2020 - 05/2010
3	Heart Failure 04/2024 - 02/2005
3	Non-alcoholic Fatty Liver Disease 01/2018 - 08/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 02/2008
2	Tuberculosis (Tuberculoses) 11/2023 - 06/2011
2	Atherosclerosis 11/2023 - 06/2006
2	Vascular Diseases (Vascular Disease) 01/2023 - 07/2003
2	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2018
2	Carcinogenesis 01/2020 - 01/2018
2	Hyperglycemia 01/2018 - 05/2008
2	Heart Diseases (Heart Disease) 01/2016 - 02/2005
2	Disease Progression 08/2015 - 02/2008
1	Cardiomegaly (Heart Hypertrophy) 02/2024
1	Neurocognitive Disorders (Clerambault Syndrome) 11/2023
1	Prediabetic State (Prediabetes) 01/2021
1	Proteinuria 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Papilloma (Papillomatosis) 01/2020
1	Abdominal Obesity 01/2020
1	Hyperprolactinemia 01/2019
1	Chronic Hepatitis C 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hypertriglyceridemia 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Hypertension (High Blood Pressure) 08/2017
1	Fetal Alcohol Spectrum Disorders 01/2014
1	Microcephaly 01/2013

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2021 - 07/2003
7	Interleukin-18 (Interleukin 18)IBA 10/2015 - 02/2005
5	Insulin (Novolin)FDA Link 01/2021 - 02/2007
4	ChemokinesIBA 06/2011 - 07/2003
3	LigandsIBA 11/2023 - 10/2002
3	HDL CholesterolIBA 01/2021 - 07/2017
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2017
3	Matrix Metalloproteinases (MMPs)IBA 12/2019 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017 - 07/2003
3	CCR5 Receptors (CCR5 Receptor)IBA 08/2015 - 02/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 04/2024 - 01/2012
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2024 - 01/2012
2	CC ChemokinesIBA 11/2023 - 10/2002
2	Carotenoids (Carotene)IBA 01/2021 - 07/2017
2	HDL LipoproteinsIBA 01/2020 - 07/2017
2	LipidsIBA 01/2020 - 07/2017
2	Uric Acid (Urate)IBA 01/2020 - 01/2018
2	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2020 - 01/2018
2	Interleukin-2 (IL2)IBA 01/2019 - 08/2017
2	acylcarnitineIBA 01/2018 - 01/2018
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2018 - 10/2014
2	Interleukin-6 (Interleukin 6)IBA 08/2017 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 02/2007
2	AldosteroneIBA 01/2016 - 10/2015
2	Transcription Factors (Transcription Factor)IBA 08/2015 - 01/2011
2	Atrial Natriuretic Factor (ANF)IBA 10/2014 - 02/2005
2	Chemotactic FactorsIBA 01/2008 - 10/2002
1	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2024
1	C.I. direct red 80IBA 02/2024
1	Messenger RNA (mRNA)IBA 02/2024
1	MicroRNAs (MicroRNA)IBA 02/2024
1	Minocycline (Cyclops)FDA LinkGeneric 02/2024
1	empagliflozinIBA 01/2023
1	Natriuretic PeptidesIBA 01/2021
1	sacubitrilIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	EnzymesIBA 01/2021
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2021
1	Valsartan (Vals)FDA Link 01/2021
1	LDL CholesterolIBA 01/2020
1	ProlactinIBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Cimetidine (Biomet)FDA LinkGeneric 01/2019
1	levosulpirideIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2018
1	Amino Acids FDA Link 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Retinaldehyde (Retinal)IBA 08/2017
1	InterferonsIBA 08/2017
1	PhytochemicalsIBA 07/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2016
1	Apoptosis Regulatory ProteinsIBA 01/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	Neutralizing AntibodiesIBA 01/2012
1	Carrier Proteins (Binding Protein)IBA 01/2012

Therapy/Procedure

2	Therapeutics 04/2024 - 01/2021